SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

Autres langues Shanghai Yizhong Pharmaceutical Co., Ltd.

Actions

688091

CNE1000050F4

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
39,4 ^CNY	+2,55 %		-0,05 %	-38,44 %

30/04	Les actions de la Chine continentale en baisse avant le long congé de la fête du travail, les actions de Hong Kong en hausse	RE
29/04	Shanghai Yizhong Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	30/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%	05/02
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator	27/10/23
Shanghai Yizhong Pharmaceutical Co., Ltd.(XSSC:688091) added to S&P Global BMI Index	18/09/23
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2023.	09/09/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Chinese Oncology Body Includes Yizhong Pharma's Drug in Non-Small Cell Lung Cancer Treatment Guidelines	24/04/23
Yizhong Pharma Gets Nod to Trial Lung Cancer Drug in China	17/04/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	19/10/22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange A Share Index	09/09/22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange Composite Index	09/09/22
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2022.	09/09/22
Shanghai Yizhong Pharmaceutical’s CFO Steps Down; Successor Named	18/08/22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	17/08/22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/04/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shanghai Yizhong Pharmaceutical Co., Ltd.

Actions

688091

CNE1000050F4

Autres langues

Filtres